Watch breaking news videos and read news updates about Pfizer on FOXBusiness.com.
LATEST VIDEOS
What Big Pharma Gains From Health Reform
10/19/2009|FOX Business
Leerink Swann's John Sullivan on health reform's impact on the pharmaceutical industry.
Ireland's Minister for Foreign Affairs Micheal Martin on his plans for Ireland's economy.
We break down if the government spending plan has hit the mark or missed its target.
Pfizer faces a setback, halting enrollments in a clinical trial. Meanwhile, Citi faces a fine.
Cody sounds off on why one-third of Wall Street is hungry for more cash.
Gov't too Price-Conscious on Health Care?
08/27/2009|FOX Business
FBN's Liz MacDonald on how the government views health-care costs.
Muriel Siebert on Markets, Kennedy
08/26/2009|FOX Business
Muriel Siebert & Co. CEO Muriel Siebert on the state of the markets.
The Cincinnati Enquirer reporter David Holthaus and Leerink Swann Managing Director Adam Berger on P&G's deal to sell its prescription drug business.
As the market continues to fight for a rebound where does your retirement plan stand? Check out the full hour of FOXBusiness.com LIVE today.
Health Insurers the Scapegoat?
08/12/2009|Happy Hour on FOX Business
Acorda Capital Management Managing Director Scott Gottlieb on reports that health insurers helped write health-care legislation even though President Obama blamed them for many of the problems in health care.
LATEST STORIES
Vivus Reports Postive Study Results For ED Drug
| MarketWatch Pulse| Markets
can effectively compete in the oral ED therapy market," Wilson added. Other PDE5 inhibitors for ED include Eli Lilly & Co.'s Cialis, Pfizer Inc.'s Viagra, and GlaxoSmithKline plc's Levitra. Copyright © 2009 MarketWatch, Inc.
Story|11/18/2009
Bausch & Lomb Names Former Schering CEO to Board
FOXBusiness| Markets
2003 until the company was acquired by Merck (MRK) in October. Hassan previously worked for Pharmacia, which was sold to Pfizer (PFE) in 2003. On Thursday, Bausch & Lomb Chairman and CEO Gerald Ostrov said, "We will especially value Fred's insights
Story|11/12/2009
Tuesday Stories: Life On Severance; New York “On The Brink;” Digital Distractions « The Brian
The Brian Sullivan Blog
entitlement spending Dodd unveiling financial reform plan Counting the jobs created by stimulus Taxing Private Ryan Bullish on Walmart Pfizer slashing R&D spending, closing facilities Krugman: How much was Reagan's fault? Should we tax soda and sugar-rich fruit
Blog|11/10/2009
Pfizer to Reduce Research Operations
| FOXBusiness| Markets
Wyeth last month, pharmaceutical colossus Pfizer (PFE) announced plans to close six of its research ..... will address unmet medical need and bring Pfizer ’s scientific and competitive advantage ..... improve productivity while cutting costs. Pfizer said the changes would reduce square footage
Story|11/09/2009
Pfizer To Shutter Six Out Of 20 R&D Sites
| MarketWatch Pulse| Markets
Witkowski MarketWatch Pulse SAN FRANCISCO -- Pfizer Inc. said Monday it will "significantly ..... sites and shut down six out its 20 sites. Pfizer said it will shut down its R&D operations ..... and St. Louis to other locations. Pfizer said the moves will result in staff reductions
Story|11/09/2009
| MarketWatch| Markets
would earn 46 cents a share on $2.9 billion in revenue. Pfizer Inc. (PFE) said its board has approved the measure of giving ..... on executive compensation. The first vote will take place at Pfizer 's 2010 annual shareholders meeting and will occur again every
Story|10/29/2009
Pfizer To Allow Shareholder Vote On Executive Pay
| MarketWatch Pulse| Markets
Wallace Witkowski MarketWatch Pulse SAN FRANCISCO -- Pfizer Inc. said late Thursday that its board has approved the measure ..... on executive compensation. The first vote will take place at Pfizer 's 2010 annual shareholders meeting and occur every other year
Story|10/29/2009
Pfizer Employs Unique Strategy of 'More Is Less'
| FOXBusiness| Markets
Dunstan Prial FOXBusiness Pfizer Chief Executive Officer Jeff Kindler seems to want it both ways. He wants Pfizer (PFE) to remain the largest drug maker ..... pushing his company in both directions. Pfizer ’s recent third-quarter results suggest
Story|10/28/2009
Drug Stocks Decline; Pfizer Rises On Earnings
| MarketWatch Pulse| Markets
Drug stocks declined in early trading Tuesday as shares of Pfizer Inc. rose after it issued a better-than-expected earnings ..... Biotechnology Index was down 1.4% at 917.34. Shares of Pfizer were up almost 2% at $18.29. Copyright © 2009 MarketWatch
Story|10/20/2009
Pfizer Profit Rises in 3Q, Tops Street
Reuters| Markets
Reuters NEW YORK-- Pfizer Inc (PFE) reported higher third-quarter ..... share, a year ago. Excluding items, Pfizer earned 51 cents per share. Analysts ..... analysts' estimates of $11.41 billion. Pfizer 's bought Wyeth to help soften the 2011
Story|10/20/2009